Topics:

Diabetes

SGLT2 Inhibitors: Basic Training Quiz

The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.

Diabetes

The new guidelines signal a shift toward aggressive treatment for obesity as a primary disease and following with treatment for comorbidites that do not respond to weight loss.

Long-term use of this SGLT2 inhibitor revealed sustained clinical benefits in older patients with diabetes and most AEs reported were mild.

 SGLT2-I Use in the Elderly

SGLT2 inhibitors perform well in older patients and cause minimal hypoglycemia. But caution is advised and here are 5 reasons why.

Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.

In the international diabetes community the topic of hemoglobin A1c (HbA1c) continues to generate controversy for a number of reasons. 

Three-quarters of persons with diabetes will experience significant gastrointestinal symptoms. What underlies the evolution of these GI ailments?

Recommendations from the American Diabetes Association also suggest a less stringent diastolic blood pressure target, all in keeping with recent changes in cardiovascular risk management guidelines.

Pages

Subscribe to Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.